DOI:
10.1055/s-00032260
Digestive Disease Interventions
LinksClose Window
References
Ott PA, Piha-Paul SA, Munster P. et al.
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with recurrent carcinoma of the anal canal.
Ann Oncol 2017;
28 (05) 1036-1041
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.